Seroprevalencia y transmisión vertical de enfermedad de Chagas en una cohorte de gestantes latinoamericanas en un hospital terciario de Madrid

Francisco-González, Laura; Gastañaga-Holguera, Teresa; Jiménez Montero, Beatriz; Daoud Pérez, Zarife; Illán Ramos, Marta; Merino Amador, Paloma; Herráiz Martínez, Miguel Ángel; Ramos Amador, José Tomás.
An. pediatr. (2003. Ed. impr.) ; 88(3): 122-126, mar. 2018.
Artículo en Español | IBECS (España) | ID: ibc-172363

Documentos relacionados

  1. Why do we still have not a vaccine against Chagas disease?
  2. Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection.
  3. Memory-like NK Cells Are a Critical Component of Vaccine-Induced Immunity to Trypanosoma cruzi Infection.
  4. Modeling the impact of xenointoxication in dogs to halt Trypanosoma cruzi transmission.
  5. Chagas disease.
  6. The multidimensional comprehension of Chagas disease. Contributions, approaches, challenges and opportunities from and beyond the Information, Education and Communication field.
  7. Oral transmission of Chagas disease from a One Health approach: A systematic review.
  8. Immunoglobulin and T cell receptor repertoire changes induced by a prototype vaccine against Chagas disease in naïve rhesus macaques.
  9. Do the new triatomine species pose new challenges or strategies for monitoring Chagas disease? An overview from 1979-2021.
  10. Congenital Chagas disease: progress toward implementation of pregnancy-based screening.